Publicaciones en las que colabora con ROBERT CARLES CALLAGHAN PITLIK (12)

2017

  1. Characterization of the new human pleomorphic undifferentiated sarcoma TP53-null cell line mfh-val2

    Cytotechnology, Vol. 69, Núm. 4, pp. 539-550

2015

  1. Alteration of major vault protein in human glioblastoma and its relation with EGFR and PTEN status

    Neuroscience, Vol. 297, pp. 243-251

  2. Evolution to malignancy: A genetic stepwise study of tumor suppressor genes loss in a recurrent meningioma

    Clinical Neuropathology

  3. Expression of the Chemokine Receptors CXCR3, CXCR4, CXCR7 and Their Ligands in Rhabdomyosarcoma

    Pathology and Oncology Research, Vol. 21, Núm. 4, pp. 1191-1199

2014

  1. BRAF V600E mutation in two distinct meningeal melanocytomas associated with a nevus of ota

    Journal of Clinical Oncology, Vol. 32, Núm. 20

  2. Correlation between EGFR amplification and the expression of MicroRNA-200c in primary glioblastoma multiforme

    PLoS ONE, Vol. 9, Núm. 7

2013

  1. Chromosomal and genetic changes produced in tumoral progression of embryonal rhabdomyosarcoma

    Histopathology

2012

  1. Characterization of a new human melanoma cell line with CD133 expression

    Human Cell, Vol. 25, Núm. 2, pp. 61-67

2007

  1. Concurrent EGFR amplification and TP-53 mutation in glioblastomas

    Clinical Neuropathology, Vol. 26, Núm. 5, pp. 224-231

2005

  1. Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme

    Clinical Neuropathology, Vol. 24, Núm. 5, pp. 209-218

2004

  1. Association of loss of 1p and alterations of chromosome 14 in meningioma progression

    Cancer Genetics and Cytogenetics, Vol. 148, Núm. 2, pp. 123-128

1999

  1. Prognostic significance of histologic and cytometric factors in supratentorial astrocytomas: A retrospective study on 116 tumors

    International Journal of Surgical Pathology, Vol. 7, Núm. 4, pp. 205-215